Back to school: Shire trains at NIBRT ahead of biologics site opening

By Flora Southey contact

- Last updated on GMT

GettyImages/Romanovskyy
GettyImages/Romanovskyy
Shire is sending its employees to the National Institute for Bioprocessing and Research Training prior to opening its biomanufacturing site in Dunboyne, Ireland.

Under the professional training and development collaboration, Shire will employ the NIBRT-GE Single Use Technology Centre of Excellence​ and Emerson manufacturing automation platform​ to cover all aspects of biopharma manufacturing.

While all Dunboyne-based employees will receive training, the National Institute for Bioprocessing and Research Training (NIBRT) will train 20 staff members on-site for a period of 12 months.

NIBRT spokesperson Alison Quinn told us employees – who will receive training for the duration of the commissioning, validation, and start-up of the Dunboyne site – will develop quality processes while at the institute. 

“Training will cover all aspects of the biopharma manufacturing process, with a focus on cell culture, downstream processing, and bioanalytics,” ​she told us.

Shire’s employees will begin training in Q3, 2018.

Single-use at Dunboyne

Shire announced plans​ to construct the $400m biologics manufacturing facility in April, 2016.

A spokesperson told us the 120-acre campus will “adopt single use technology in the manufacturing processes, will be a highly automated facility and will also be the European Quality Control Hub for Shire’s biologics portfolio.”

The expansion – which will create approximately 400 jobs – responds to an increase in product demand, she added.

Related news

Show more

Related products

show more

Strategies for Upstream Intensification

Strategies for Upstream Intensification

Take the Right Path Upstream with MilliporeSigma | 01-Sep-2020 | Technical / White Paper

The Facility of the Future represents a transformation in how biologics are developed and manufactured.

Rapid Biosafety Testing Enables the Future of Manufacturing

Rapid Biosafety Testing Enables the Future of Manufacturing

Viral Safety for mAb: Prevent, Detect, Remove | 05-Aug-2020 | Technical / White Paper

Traditional methods for adventitious agent testing rely on biological amplification and detection, which can take several weeks. This time-consuming approach...

Related suppliers

Follow us

Products

View more

Webinars